Wordt geladen...
Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. However, native CT is highly toxic to be used as a mucosal adjuvant in humans. Here, we demonstrate a new approach to generate a mucosal adjuvant by replacing the B subunit of CT with...
Bewaard in:
| Gepubliceerd in: | J Immunol Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863330/ https://ncbi.nlm.nih.gov/pubmed/29707588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9830701 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|